All Mark Kieh articles

  • Ebola virus
    News

    Phase 2 trial of Ebola vaccines yields promising results

    2022-12-14T22:00:00Z

    An international team of scientists has published the results of a large-scale randomized clinical trial in West Africa which confirms the safety of three vaccine regimens for Ebola and suggests an immune response is induced and maintained for up to 12 months.